In healthcare SaaS, where enterprise sales cycles are long and often involve clinical, financial, and IT stakeholders, the pipeline is the leading indicator of whether revenue will materialize quarters from now. But pipeline discipline is not a forecasting exercise. It is a leadership test.
A pipeline only works when it reflects buyer commitment, not seller activity. When leaders in complex hospital and payer environments confuse motion with progress, the unraveling is usually visible long before the quarter misses.
Bradley Roger Swenson, a healthcare SaaS revenue leader and advisor, argues that pipeline failures are rarely surprises. They are the natural consequence of structural weaknesses that were present all along.
“Volume is masking quality,” he says. “We have a 6 to 1 ratio in our pipeline and the executive team and boards feel good about that. But when you really inspect the deals, you start to see a lack of decision criteria.
When Coverage Ratios Create False Confidence
A healthy coverage ratio can reassure even seasoned executives. Carrying six times quarterly target in pipeline appears to provide insulation from deal slippage or last-minute losses. Ratios alone, however, say nothing about deal integrity.
The first crack typically appears in decision clarity. Does the team understand how the customer will make a decision? Is there a defined economic buyer? Are next steps documented and mutually agreed upon?
Without that foundation, stage progression becomes administrative rather than substantive. Deals advance in CRM because meetings occurred, not because decisions moved forward.
The second warning sign is activity without ownership.
“We can get really comfortable with lots of meetings happening and deals advancing stages,” Swenson says. “But what’s missing is buyer-owned actions.”
A customer scheduling an internal board review or initiating an information security assessment carries weight. A sales rep logging another follow-up meeting does not.
When progression is seller-led rather than buyer-led, pipeline health becomes an illusion.
The Subtle Drift Toward “Happy Talk”
Go-to-market teams often reinforce this illusion through superficial qualification. Frameworks such as MEDPICC are designed to introduce rigor. Used mechanically, they can create false comfort.
“We find some comfort if we check the boxes,” Swenson says. “But are we truly clear on who the economic buyer is? Do we truly have a champion? Do we have a backup champion?”
When qualification becomes performative, culture shifts. Teams stop trying to be right and start trying not to be wrong.
The antidote is disciplined risk inspection.
“We take pride in looking for risk and then de-risking a deal,” he says. “If we can’t find risk in a deal, something’s wrong. There’s always risk.”
In high-performing organizations, surfacing risk is a mark of professionalism, not pessimism.
Demonstrating Value in the Customer’s Language
Pipeline erosion also stems from misalignment between product messaging and customer reality. Healthcare SaaS companies are adept at describing value in broad strokes. The problem is specificity.
“In the client’s words, what is the problem they have, and how very specifically are we going to drive value in solving it?” Swenson says.
Without anchoring value to the customer’s stated consequences, opportunities remain conceptual.
The standard software demo often reinforces the gap.
“As a SaaS company, we go in and educate them on our software. What a waste of time,” he says. “The demo needs to be rooted in how we fix that problem and what value that creates.”
When demonstrations focus on features instead of outcomes, deals linger. Six months becomes twelve. Energy drains from the team. Forecasts swell with opportunities that feel active but lack urgency.
Swenson advocates for a fail-fast mindset. Push early for a mutual action plan. Tie every interaction to a concrete step in the customer’s decision process.
“The worst thing we can do is let deals sit in the pipeline for six months, 12 months, or longer,” he says. “That’s just wasted time and energy.”
Turning Pipeline Reviews Into Decision Factories
Preventing collapse requires executive involvement well before the final stage. Swenson encourages leaders to build what he calls a decision factory, a system in which every interaction helps the buyer move toward a defined outcome.
Mutual action plans sit at the center. Clear timelines, named stakeholders, and explicit responsibilities transform optimism into accountability.
If the customer is not executing their side of the plan, “that’s not a real deal,” Swenson says. It should not carry the same weight in the forecast as an opportunity with visible buyer movement.
He also recommends pre-mortems. Take the top three deals in the pipeline and assume they are lost. Conducting that exercise before the quarter closes reframes pipeline reviews from storytelling sessions into disciplined risk assessments.
Ultimately, Swenson places responsibility where it belongs. Pipeline failure is not primarily a sales rep flaw. It reflects how rigorously leaders inspect for buyer signals, reinforce clarity, and create safety around uncomfortable truths.
“It doesn’t have to be so complicated,” he says. “There are straightforward disciplines we can apply.”
Those disciplines, applied consistently, determine whether a pipeline merely looks healthy or truly sustains growth.
Follow Bradley Roger Swenson on LinkedIn or visit his website for more insights.
